Literature DB >> 25070057

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.

Francis M Giardiello1, John I Allen2, Jennifer E Axilbund1, C Richard Boland3, Carol A Burke4, Randall W Burt5, James M Church4, Jason A Dominitz6, David A Johnson7, Tonya Kaltenbach8, Theodore R Levin9, David A Lieberman10, Douglas J Robertson11, Sapna Syngal12, Douglas K Rex13.   

Abstract

The Multi-Society Task Force, in collaboration with invited experts, developed guidelines to assist health care providers with the appropriate provision of genetic testing and management of patients at risk for and affected with Lynch syndrome as follows: Figure 1 provides a colorectal cancer risk assessment tool to screen individuals in the office or endoscopy setting; Figure 2 illustrates a strategy for universal screening for Lynch syndrome by tumor testing of patients diagnosed with colorectal cancer; Figures 3,4,5,6 provide algorithms for genetic evaluation of affected and at-risk family members of pedigrees with Lynch syndrome; Table 10 provides guidelines for screening at-risk and affected persons with Lynch syndrome; and Table 12 lists the guidelines for the management of patients with Lynch syndrome. A detailed explanation of Lynch syndrome and the methodology utilized to derive these guidelines, as well as an explanation of, and supporting literature for, these guidelines are provided.

Entities:  

Mesh:

Year:  2014        PMID: 25070057     DOI: 10.1038/ajg.2014.186

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  139 in total

1.  The American Journal of Gastroenterology in 2016: Where Have We Been? Where Are We Going?

Authors:  Brian E Lacy; Brennan Spiegel
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

2.  DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.

Authors:  Nicole de Rosa; Miguel A Rodriguez-Bigas; George J Chang; Jula Veerapong; Ester Borras; Sunil Krishnan; Brian Bednarski; Craig A Messick; John M Skibber; Barry W Feig; Patrick M Lynch; Eduardo Vilar; Y Nancy You
Journal:  J Clin Oncol       Date:  2016-07-18       Impact factor: 44.544

Review 3.  Recent advances in Lynch syndrome.

Authors:  Leah H Biller; Sapna Syngal; Matthew B Yurgelun
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

4.  Genetic polymorphisms in CDH1 are associated with endometrial carcinoma susceptibility among Chinese Han women.

Authors:  Yue-Hang Geng; Zi-Fan Wang; Yu-Mian Jia; Li-Yuan Zheng; Lan Chen; Dong-Ge Liu; Xiang-Hong Li; Xin-Xia Tian; Wei-Gang Fang
Journal:  Oncol Lett       Date:  2018-09-20       Impact factor: 2.967

Review 5.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

6.  Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.

Authors:  Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Dallas English; Mark A Jenkins; Stine V Eriksen; Michael D Walsh; Rhiannon J Walters; Stephen N Thibodeau; Jenna Stewart; Susan Preston; Aung Ko Win; Louisa Flander; Driss Ait Ouakrim; Finlay A Macrae; Alex Boussioutas; Ingrid M Winship; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  J Gastroenterol Hepatol       Date:  2017-02       Impact factor: 4.029

7.  Identifying persons with Lynch syndrome: why and how?

Authors:  Uri Ladabaum
Journal:  Dig Dis Sci       Date:  2014-12       Impact factor: 3.199

8.  Guidelines on genetic evaluation and management of Lynch syndrome.

Authors:  Winand N M Dinjens; Hendrikus J Dubbink; Anja Wagner
Journal:  Am J Gastroenterol       Date:  2015-01       Impact factor: 10.864

9.  New strategies immediately needed for molecular marker reporting in colorectal cancer.

Authors:  Daniel A Sussman; Monique N Hernandez; Stacey L Tannenbaum; Judith M Bonner; L A McClure; D J Lee
Journal:  Am J Gastroenterol       Date:  2015-01       Impact factor: 10.864

10.  Screening for Lynch syndrome: it is time to shift the focus.

Authors:  Trilokesh D Kidambi; Jonathan P Terdiman
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.